# Caelyx Adjuvant in Elderly Breast Cancer

> **NCT00284336** · PHASE2 · COMPLETED · sponsor: **Universitaire Ziekenhuizen KU Leuven** · enrollment: 16 (—)

## Conditions studied

- Breast Cancer
- Elderly

## Interventions

- **DRUG:** Caelyx
- **DRUG:** endoxan

## Key facts

- **NCT ID:** NCT00284336
- **Lead sponsor:** Universitaire Ziekenhuizen KU Leuven
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** —
- **Final completion:** 2007-04
- **Target enrollment:** 16 (—)
- **Last updated:** 2014-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00284336

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00284336, "Caelyx Adjuvant in Elderly Breast Cancer". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT00284336. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*